Scope Law advises Swiss biotech startup in negotiating a license agreement to out license a platform-technology developed by it for commercialization by the licensee together with venture capital investors.
top of page
Recent Posts
See AllScope Law advises ETFbook , Zurich, in its EUR 4 million Series A financing round, led by BlackFin Capital Partners BlackFin Capital...
Scope Law advises qCella AG , Zurich, a spin-off of ETH Zurich in its CHF 1.3 million pre-seed financing round. Participating investors...
Scope Law acts as Swiss legal counsel to the sole shareholder and managing director of NCD Ingredients GmbH (Germany) on the sale of all...
bottom of page
Comments